PMC:7396557 / 72310-72650 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T728","span":{"begin":109,"end":122},"obj":"PR:000001091"},{"id":"T729","span":{"begin":131,"end":135},"obj":"PR:000001393"},{"id":"T730","span":{"begin":141,"end":146},"obj":"PR:000000134"},{"id":"T731","span":{"begin":164,"end":167},"obj":"PR:000001004"},{"id":"T732","span":{"begin":174,"end":186},"obj":"CL:0000084"},{"id":"T733","span":{"begin":268,"end":276},"obj":"GO:0006955"},{"id":"T78652","span":{"begin":109,"end":122},"obj":"PR:000001091"},{"id":"T86795","span":{"begin":131,"end":135},"obj":"PR:000001393"},{"id":"T71515","span":{"begin":141,"end":146},"obj":"PR:000000134"},{"id":"T51323","span":{"begin":164,"end":167},"obj":"PR:000001004"},{"id":"T47561","span":{"begin":174,"end":186},"obj":"CL:0000084"},{"id":"T60806","span":{"begin":268,"end":276},"obj":"GO:0006955"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T388","span":{"begin":109,"end":122},"obj":"Body_part"},{"id":"T389","span":{"begin":124,"end":128},"obj":"Body_part"},{"id":"T390","span":{"begin":174,"end":186},"obj":"Body_part"},{"id":"T391","span":{"begin":197,"end":204},"obj":"Body_part"},{"id":"T392","span":{"begin":200,"end":204},"obj":"Body_part"}],"attributes":[{"id":"A388","pred":"fma_id","subj":"T388","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A389","pred":"fma_id","subj":"T389","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A390","pred":"fma_id","subj":"T390","obj":"http://purl.org/sig/ont/fma/fma62870"},{"id":"A391","pred":"fma_id","subj":"T391","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A392","pred":"fma_id","subj":"T392","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T458","span":{"begin":310,"end":319},"obj":"Disease"}],"attributes":[{"id":"A458","pred":"mondo_id","subj":"T458","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T678","span":{"begin":109,"end":122},"obj":"http://purl.obolibrary.org/obo/PR_000001091"},{"id":"T679","span":{"begin":164,"end":167},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T680","span":{"begin":169,"end":172},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T681","span":{"begin":197,"end":204},"obj":"http://purl.obolibrary.org/obo/CL_0000623"},{"id":"T682","span":{"begin":214,"end":222},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T172","span":{"begin":124,"end":126},"obj":"Chemical"},{"id":"T174","span":{"begin":131,"end":133},"obj":"Chemical"}],"attributes":[{"id":"A26696","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A64911","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A29041","pred":"chebi_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A8722","pred":"chebi_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T87","span":{"begin":232,"end":253},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T540","span":{"begin":0,"end":340},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T293","span":{"begin":310,"end":319},"obj":"Phenotype"}],"attributes":[{"id":"A293","pred":"hp_id","subj":"T293","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2052","span":{"begin":109,"end":122},"obj":"Gene"},{"id":"2053","span":{"begin":124,"end":128},"obj":"Gene"},{"id":"2054","span":{"begin":131,"end":135},"obj":"Gene"},{"id":"2055","span":{"begin":141,"end":146},"obj":"Gene"},{"id":"2056","span":{"begin":164,"end":167},"obj":"Gene"},{"id":"2057","span":{"begin":169,"end":172},"obj":"Gene"},{"id":"2068","span":{"begin":289,"end":297},"obj":"Species"},{"id":"2084","span":{"begin":310,"end":319},"obj":"Disease"}],"attributes":[{"id":"A2052","pred":"tao:has_database_id","subj":"2052","obj":"Gene:3552"},{"id":"A2053","pred":"tao:has_database_id","subj":"2053","obj":"Gene:3552"},{"id":"A2054","pred":"tao:has_database_id","subj":"2054","obj":"Gene:3569"},{"id":"A2055","pred":"tao:has_database_id","subj":"2055","obj":"Gene:7124"},{"id":"A2056","pred":"tao:has_database_id","subj":"2056","obj":"Gene:920"},{"id":"A2057","pred":"tao:has_database_id","subj":"2057","obj":"Gene:925"},{"id":"A2068","pred":"tao:has_database_id","subj":"2068","obj":"Tax:9606"},{"id":"A2084","pred":"tao:has_database_id","subj":"2084","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Research by Yin Teng et al. found that XBJI in combination with conventional treatment significantly reduced interleukin-1 (IL-1), IL-6, and TNF-α levels, improved CD4+/CD8+ T lymphocyte ratio and NK cell relative activity, reduced inflammatory response, and enhanced cellular immunity in patients with severe pneumonia (Teng et al., 2012)."}